[Federal Register Volume 66, Number 106 (Friday, June 1, 2001)]
[Notices]
[Page 29835]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-13771]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Inter Company Collaboration for Aids Drug 
Development

    Notice is hereby given that, on March 6, 2001, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), the Inter Company Collaboration 
for AIDS Drug Development (the ``Collaboration'') filed written 
notifications simultaneously with the Attorney General and the Federal 
Trade Commission disclosing changes in its membership status. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances. Specifically, although no 
changes have been made in the membership of the Collaboration, members 
Glaxo Wellcome plc, Research Triangle Park, NC; and SmithKline Beecham 
plc, Philadelphia, PA have merged by agreeing to be acquired by a 
common parent company, GlaxoSmithKline plc., Research Triangle Park, 
NC.
    No other changes have been made in either the membership or planned 
activity of the Collaboration. Membership in the Collaboration remains 
open, and the Collaboration intends to file additional written 
notification disclosing all changes in membership.
    On May 27, 1993, the Collaboration filed its original notification 
pursuant to Section 6 (a) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to Section 6 (b) of 
the Act on July 6, 1993 (58 FR 36223).
    The last notification was filed with the Department on August 18, 
2000. A notice was published in the Federal Register pursuant to 
Section 6 (b) of the Act on October 6, 2000, (65 FR 59874).

Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 01-13771 Filed 5-31-01; 8:45 am]
BILLING CODE 4410-11-M